Because revenue took a very sharp decline when ozempic was approved.... which caused it to not be able to service debt. The company is worth zero. It was worth

Because revenue took a very sharp decline when ozempic was approved.... which caused it to not be able to service debt. The company is worth zero. It was worth zero the minute the GLP-1s became viable. Whether it was financed with debt or equity matters not.